Professional Documents
Culture Documents
Myocardial Infarction
(NSTEMI)
BAES, FAITH CHRISLYN M. | 3B-PH
Non-ST-elevation Myocardial Infarction
- "intermediate" form of Acute Coronary Syndrome,
a blockage either occurs in a minor coronary artery
or causes partial obstruction of a major coronary
artery. It causes less damage to the heart.
How is a NSTEMI diagnosed?
when symptoms of unstable angina are accompanied by
evidence of myocardial necrosis
Electrocardiogram: ST depression and/or T Inversion
Cardiac troponin: by far the most commonly used
biomarker. It has the highest known sensitivity.
DRUG THERAPY
Antithrombitic Agents:
Aspirin 325 mg:
- irreversible cyclooxygenase inhibitor
- helps to thin the blood and keep platelets in the blood
from clumping together
Clopidogrel 300-600 mg, Ticagrelor 180 mg, Prasugrel 60 mg:
- irreversibly binds to the P2Y12 receptor, except for
Ticagrelor
- adverse effects include gastrointestinal discomfort and
increased bleeding
Anticoagulant Agents:
Unfractionated heparin 60 U/kg
LWM heparin (Enoxaparin 1mg/kg SC)
Fondaparinux 2.5 mg SC
- work by inhibiting blood clotting, either by antagonizing the
effects of vitamin K or by blocking/inhibiting thrombin.
ADR: excessive bleeding, diarrhea, dizziness, and headaches
Anti-ischemic therapies:
Nitroglycerin 0.3-0.6 mg sublingually or buccal spray
- benefit by giving rise to nitric oxide (NO), which causes
vasodilation and increases blood flow to the myocardium